S&P 500   3,005.99 (+0.66%)
DOW   26,834.53 (+0.24%)
QQQ   193.31 (+0.85%)
AAPL   240.27 (+1.63%)
FB   189.42 (+1.92%)
MSFT   138.18 (+0.56%)
GOOGL   1,244.61 (+0.02%)
AMZN   1,782.65 (+1.43%)
CGC   20.35 (+0.69%)
NVDA   195.85 (+2.81%)
MU   45.11 (+3.75%)
BABA   173.84 (+2.78%)
GE   8.80 (-1.90%)
TSLA   253.25 (-1.44%)
AMD   32.01 (+3.36%)
T   38.26 (-0.55%)
F   9.01 (-3.01%)
NFLX   277.61 (+0.84%)
BAC   31.12 (+2.50%)
GILD   65.17 (+0.40%)
S&P 500   3,005.99 (+0.66%)
DOW   26,834.53 (+0.24%)
QQQ   193.31 (+0.85%)
AAPL   240.27 (+1.63%)
FB   189.42 (+1.92%)
MSFT   138.18 (+0.56%)
GOOGL   1,244.61 (+0.02%)
AMZN   1,782.65 (+1.43%)
CGC   20.35 (+0.69%)
NVDA   195.85 (+2.81%)
MU   45.11 (+3.75%)
BABA   173.84 (+2.78%)
GE   8.80 (-1.90%)
TSLA   253.25 (-1.44%)
AMD   32.01 (+3.36%)
T   38.26 (-0.55%)
F   9.01 (-3.01%)
NFLX   277.61 (+0.84%)
BAC   31.12 (+2.50%)
GILD   65.17 (+0.40%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AmgenGilead SciencesBiogenNOVOZYMES A/S/SSeattle Genetics
SymbolNASDAQ:AMGNNASDAQ:GILDNASDAQ:BIIBOTCMKTS:NVZMYNASDAQ:SGEN
Price Information
Current Price$202.69$65.11$224.60$42.91$101.95
52 Week RangeBuyBuyHoldHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$217.29$81.95$263.52N/A$87.92
% Upside from Price Target7.21% upside25.87% upside17.33% upsideN/A-13.76% downside
Trade Information
Market Cap$122.08 billion$82.53 billion$41.61 billion$12.70 billion$13.90 billion
Beta1.111.11.020.751.95
Average Volume2,185,5975,886,7021,852,74629,1021,119,741
Sales & Book Value
Annual Revenue$23.75 billion$22.13 billion$13.45 billion$2.28 billion$654.70 million
Price / Sales5.123.733.085.5925.18
Cashflow$18.00 per share$7.32 per share$31.59 per share$1.73 per shareN/A
Price / Cash11.268.907.1124.84N/A
Book Value$19.62 per share$16.65 per share$64.68 per share$6.10 per share$7.95 per share
Price / Book10.333.913.477.0312.82
Profitability
Net Income$8.39 billion$5.46 billion$4.43 billion$511 million$-222,690,000.00
EPS$14.40$6.15$26.20$1.75($1.65)
Trailing P/E Ratio14.0810.598.5724.52N/A
Forward P/E Ratio13.119.496.9626.01N/A
P/E Growth$2.69$2.96$1.22$2.02N/A
Net Margins33.78%26.64%37.62%22.31%-36.94%
Return on Equity (ROE)76.17%37.12%44.89%28.54%-17.16%
Return on Assets (ROA)14.36%13.06%23.23%16.00%-14.39%
Dividend
Annual Payout$5.80$2.52N/A$0.50N/A
Dividend Yield2.86%3.87%N/A1.17%N/A
Three-Year Dividend Growth18.70%N/AN/AN/AN/A
Payout Ratio40.28%40.98%N/A28.57%N/A
Years of Consecutive Dividend Growth8 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.58%1.13%0.49%0.05%N/A
Current Ratio2.89%3.76%2.46%1.27%3.03%
Quick Ratio2.60%3.67%2.22%0.75%2.70%
Ownership Information
Institutional Ownership Percentage76.33%79.67%86.31%0.18%98.65%
Insider Ownership Percentage0.25%0.20%0.39%N/A33.80%
Miscellaneous
Employees21,50011,0007,8006,4271,302
Shares Outstanding599.70 million1.27 billion184.45 million297.00 million161.72 million
Next Earnings Date10/29/2019 (Confirmed)10/24/2019 (Confirmed)10/22/2019 (Confirmed)10/23/2019 (Confirmed)10/29/2019 (Confirmed)
OptionableOptionableOptionableOptionableNot OptionableOptionable
 AmgenGilead SciencesBiogenNOVOZYMES A/S/SSeattle Genetics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel